Venrock partner Racquel Bracken speaks with Markus Renschler, President and CEO of Cyteir Therapeutics, to discuss the journey that led him to Cyteir, and the company’s path to going public. Renschler dives into an important lesson his parents instilled in him from a young age, “be comfortable with being uncomfortable,” and explains how this lesson has played an important role in his career journey. As a practicing hematologist oncologist, Renschler highlights the value of people skills and how developing those skills can positively influence leadership style, recruiting, and even fundraising. Renschler shares some of his highs and lows along the drug development process, provides advice for young clinicians entering the industry, and how his experience as a practicing physician influences the decisions he makes as a CEO. 

  • Subscribe:

Want more? Here’s the latest on Running Through Walls.

Farzad Mostashari, founder and CEO of Aledade, speaks with Venrock’s Bryan Roberts and Bob Kocher about improving the quality and efficiency of patient care with a focus on preventative care. With the recent launch of Aledade Care Solutions and new focus on Medicare Advantage, Mostashari delves into Aledade’s efforts to scale and deliver where average primary care practices can’t. Mostashari also reveals his approach to value based care incentive structure, and why building a valuable solution requires a long time horizon.
  1. Thinking Long Term is the Greatest Gift
  2. Diversifying the Cap Table
  3. The Balancing Act of Drug Discovery
  4. Bust the Liars Without Elevating the Liars
  5. Healthy Skepticism in Product Management